Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Quinidine

Base Information Edit
  • Chemical Name:Quinidine
  • CAS No.:56-54-2
  • Deprecated CAS:11010-73-4,500225-45-6,845886-64-8,882741-47-1,883881-01-4,898814-00-1,910899-51-3,1528764-92-2,2393956-08-4,1528764-92-2,500225-45-6,845886-64-8,882741-47-1,883881-01-4,910899-51-3
  • Molecular Formula:C20H24N2O2
  • Molecular Weight:324.423
  • Hs Code.:29392000
  • European Community (EC) Number:200-279-0
  • UN Number:2811
  • UNII:ITX08688JL
  • DSSTox Substance ID:DTXSID4023549
  • Wikipedia:Quinidine
  • Wikidata:Q412496
  • NCI Thesaurus Code:C793
  • RXCUI:9068
  • Pharos Ligand ID:TTP6PN9UM1K1
  • Metabolomics Workbench ID:43177
  • ChEMBL ID:CHEMBL1294
  • Mol file:56-54-2.mol
Quinidine

Synonyms:Adaquin;Apo Quinidine;Apo-Quinidine;Chinidin;Quincardine;Quinidex;Quinidine;Quinidine Sulfate;Quinora;Sulfate, Quinidine

Suppliers and Price of Quinidine
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Quinidine
  • 50mg
  • $ 279.00
  • TRC
  • Quinidine
  • 5g
  • $ 65.00
  • Tocris
  • Quinidine
  • 50
  • $ 48.00
  • TCI Chemical
  • Quinidine >98.0%(T)
  • 25g
  • $ 131.00
  • TCI Chemical
  • Quinidine >98.0%(T)
  • 5g
  • $ 46.00
  • SynQuest Laboratories
  • (+)-Quinidine 98%
  • 5 g
  • $ 24.00
  • SynQuest Laboratories
  • (+)-Quinidine 98%
  • 25 g
  • $ 104.00
  • SynQuest Laboratories
  • (+)-Quinidine 98%
  • 100 g
  • $ 396.00
  • Sigma-Aldrich
  • Quinidine anhydrous
  • 25g
  • $ 300.00
  • Sigma-Aldrich
  • Quinidine crystallized, ≥98.0% (dried material, NT)
  • 50 g
  • $ 369.00
Total 139 raw suppliers
Chemical Property of Quinidine Edit
Chemical Property:
  • Appearance/Colour:white to light yellow crystal powder 
  • Vapor Pressure:0mmHg at 25°C 
  • Melting Point:168-172 °C(lit.) 
  • Refractive Index:1.5700 (estimate) 
  • Boiling Point:495.9 °C at 760 mmHg 
  • PKA:5.4, 10.0(at 20℃) 
  • Flash Point:253.7 °C 
  • PSA:45.59000 
  • Density:1.218 g/cm3 
  • LogP:3.11110 
  • Storage Temp.:Store at -20°C 
  • Sensitive.:Light Sensitive 
  • Solubility.:insoluble in H2O; ≥10.32 mg/mL in EtOH with ultrasonic; ≥11.95 mg/mL in DMSO 
  • Water Solubility.:0.05 g/100 mL (20 ºC) 
  • XLogP3:2.9
  • Hydrogen Bond Donor Count:1
  • Hydrogen Bond Acceptor Count:4
  • Rotatable Bond Count:4
  • Exact Mass:324.183778013
  • Heavy Atom Count:24
  • Complexity:457
  • Transport DOT Label:Poison
Purity/Quality:

99% *data from raw suppliers

Quinidine *data from reagent suppliers

Safty Information:
  • Pictogram(s): HarmfulXn 
  • Hazard Codes:Xn 
  • Statements: 22-20/21/22 
  • Safety Statements: 36-22 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Chemical Classes:Biological Agents -> Plant Toxins
  • Drug Classes:Antiarrhythmic Agents
  • Canonical SMILES:COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
  • Isomeric SMILES:COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O
  • Recent ClinicalTrials:Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.
  • Recent EU Clinical Trials:Quinidine versus verapamil in short-coupled idiopathic ventricular fibrillation: An open label, randomized crossover pilot trial
  • Recent NIPH Clinical Trials:Quinidine sulfate administration for intractable epilepsy with KCNT1 gene mutation
  • Description Quinidine is a commonly used class I antiarrhythmic drug. It is a stereoisomer of quinine, originally derived from the bark of the cinchona tree. It exerts its antiarrhythmic effects on the heart by interacting with the electrophysiology mechanisms that cause arrhythmias to modify the abnormalities in impulse initiation and conduction. Quinidine depresses normal automaticity in cardiac fibers that may act as ectopic pacemakers causing arrhythmias. Quinidine also blocks the slowly inactivating, tetrodotoxin-sensitive Na current, the slow inward calcium current (ICa), the rapid (IKr) and slow (IKs) components of the delayed potassium rectifier current, the inward potassium rectifier current (IKI), the ATP-sensitive potassium channel (IKATP) and Ito. Quinidine is a stereoisomer of the antimalarial agent quinine and a class Ia antiarrhythmic agent. Quinidine blocks the voltage-gated sodium (Nav) channel Nav1.5 in a use-dependent manner. It decreases the amplitude and duration of action potentials in isolated canine ventricular myocytes. It inhibits KKr, peak INa, and late INa (IC50s = 4.5, 11, and 12 μM, respectively) and can induce torsade de pointes in isolated rabbit hearts when used at a concentration of 1 μM. Quinidine induces QT prolongation in dogs. It also binds to M2 muscarinic acetylcholine receptors (Ki = 7.5 μM for human recombinant receptors expressed in HM2-B10 cells). Formulations containing quinidine have been used in the treatment of atrial fibrillation and ventricular arrhythmias.
  • Physical properties Appearance: Quinidine is commonly used in its sulfate form with white needle-like crystal and bitter smell. It changes color easily when exposed to light. Solubility: It was soluble in ethanol and chloroform. Its water solubility is 0.05?g/100?mL (20?°C). Specific optical rotation: 256° (c?=?1, EtOH). Melting point: 168–172?°C.
  • Uses A dextrorotatory stereoisomer of Quinine. Antiarrhythmic (class IA). Antimalarial Quinidine occurs in cinchona bark to about0.25–0.3% and also in cuprea bark. It is present in quinine sulfate mother liquor. Itis formed by isomerization of quinine. Itis used in the prevention of certain cardiacarrhythmias.
  • Indications Quinidine acts as a class I antiarrhythmic agent (Ia) in the heart. It was clinically applicable to the treatment of recurrent, documented, life-threatening ventricular arrhythmias .
  • Biological Functions Quinidine is an alkaloid obtained from various species of Cinchona or its hybrids, from Remijia pedunculata, or from quinine. Quinidine is the dextrorotatory isomer of quinine.Quinidine (Quinidex) was one of the first clinically used antiarrhythmic agents. Because of the high incidence of ventricular proarrhythmia associated with its use and numerous other equally efficacious agents, quinidine is now used sparingly. Quinidine shares all of the pharmacological properties of quinine, including antimalarial, antipyretic, oxytocic, and skeletal muscle relaxant actions.
  • Clinical Use Primary indications for the use of quinidine include (1) abolition of premature complexes that have an atrial, A-V junctional, or ventricular origin; (2) restoration of normal sinus rhythm in atrial flutter and atrial fibrillation after controlling the ventricular rate with digitalis; (3) maintenance of normal sinus rhythm after electrical conversion of atrial arrhythmias; (4) prophylaxis against arrhythmias associated with electrical countershock; (5) termination of ventricular tachycardia; and (6) suppression of repetitive tachycardia associated with Wolff- Parkinson-White (WPW) syndrome. Although quinidine often is successful in producing normal sinus rhythm, its administration in the presence of a rapid atrial rate (flutter and possibly atrial fibrillation) can lead to a further and dangerous increase in the ventricular rate secondary to inhibition of basal vagal tone upon the A-V node. For this reason, digitalis should be used before quinidine when one is attempting to convert atrial flutter or atrial fibrillation to normal sinus rhythm.
  • Drug interactions Quinidine can increase the plasma concentrations of digoxin, which may in turn lead to signs and symptoms of digitalis toxicity. Gastrointestinal, central nervous system (CNS), or cardiac toxicity associated with elevated digoxin concentrations may occur.Quinidine and digoxin can be administered concurrently; however, a downward adjustment in the digoxin dose may be required. Drugs that have been associated with elevations in quinidine concentrations include acetazolamide, the antacids magnesium hydroxide and calcium carbonate, and the H2-receptor antagonist cimetidine. Cimetidine inhibits the hepatic metabolism of quinidine. Phenytoin, rifampin, and barbiturates increase the hepatic metabolism of quinidine and reduce its plasma concentrations.
Technology Process of Quinidine

There total 120 articles about Quinidine which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Refernces Edit

SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF CERTAIN 2,3-DIHYDROIMIDAZO<1,2-A>BENZIMIDAZOLES AND INTERMEDIATES FORMED IN THEIR SYNTHESIS

10.1007/BF01146184

The research focuses on the synthesis and pharmacological activity of certain 2,3-dihydroimidazo[1,2-a]benzimidazoles and their intermediates. The purpose of the study was to explore the potential hypotensive and hypoglycemic properties of these compounds, which contain a common nitrogen atom and an imidazoline ring, and have been found to exhibit a broad spectrum of pharmacological activity. The researchers synthesized new derivatives of 9H-2,3-dihydroimidazo[1,2-a]benzimidazole and investigated their pharmacological properties, including their effects on blood sugar levels and arterial pressure in rats, as well as their influence on the enzymatic activity of cyclic AMP phosphodiesterase (cAMP PDE) and acetylcholine esterase (ACE). The chemicals used in the synthesis process included various alkyl- and aralkyl-substituted benzimidazoles, chloroethylaminobenzimidazoles, and methoxyethylaminobenzimidazoles, among others. The conclusions drawn from the study indicated that some of the synthesized imidazo[1,2-a]benzimidazole derivatives showed promising hypoglycemic and hypotensive effects, and certain compounds demonstrated inhibitory activity against cAMP PDE and ACE, suggesting potential therapeutic applications. However, the overall effectiveness of these compounds was found to be less than that of some reference preparations, such as adebite (a quinidine derivative).

The Cinchona alkaloids: A silicon-directed synthesis of some advanced intermediates

10.1021/jo00015a036

The research focuses on the synthesis of advanced intermediates of Cinchona alkaloids using silicon-directed reactions. The purpose of the study is to develop a more efficient and scalable synthetic route for these alkaloids, which are historically significant therapeutic agents, particularly quinine and quinidine. The key chemicals used in the research include benzylamine, 2-(2-bromoethyl)-1,3-dioxolane, 3-(trimethylsilyl)-2(E)-propenoyl chloride, 1-(triphenylphosphoranylidene)-2-propanone, and various other reagents such as lithium aluminum hydride, sodium borohydride, and ceric ammonium nitrate (CAN). The study concludes that a silicon-directed Baeyer-Villager oxidation is an effective method to achieve the desired transformation, yielding N-benzylmeroquinene aldehyde in good yield. The researchers also successfully synthesized alcohols 23a,b and acetates 24a,b, which are advanced intermediates for the Cinchona alkaloids. The research demonstrates the utility of silicon-directed reactions in the synthesis of complex natural products, providing a potentially more accessible route for the production of these valuable compounds.

UNE APPROCHE DE SYNTHESE DE L'ENTEROCINE ADDITION DE CARBANIONS α-SOUFRES SUR LE QUINIDE.

10.1016/S0040-4020(01)96074-0

The research focuses on the chemical transformation of the Y-lactonic function of quinide into a keto-2 d-lactone through the addition of a-thiocarbanione, as an approach to synthesize enterocine, an antibiotic active against both gram-positive and gram-negative bacteria. The study also investigates the addition of acetophenone anion on the keto group of a α-keto ester. The conclusions drawn from the research indicate that while several pathways were explored, the transformation to the desired keto-2 d-lactone was challenging, with many attempts leading to either unchanged or degraded products.

Post RFQ for Price